A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in United Therapeutics Corp stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 4,088 shares of UTHR stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,088
Previous 28,722 85.77%
Holding current value
$1.52 Million
Previous $9.15 Million 84.0%
% of portfolio
0.0%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$311.04 - $363.55 $7.66 Million - $8.96 Million
-24,634 Reduced 85.77%
4,088 $1.46 Million
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $4.9 Million - $6.85 Million
21,486 Added 296.93%
28,722 $9.15 Million
Q1 2024

May 14, 2024

BUY
$210.76 - $249.51 $1.53 Million - $1.81 Million
7,236 New
7,236 $1.66 Million
Q3 2021

Nov 12, 2021

SELL
$179.86 - $214.88 $371,950 - $444,371
-2,068 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$170.47 - $211.93 $688,528 - $855,985
-4,039 Reduced 66.14%
2,068 $371,000
Q1 2021

May 13, 2021

SELL
$153.94 - $174.85 $1.4 Million - $1.59 Million
-9,100 Reduced 59.84%
6,107 $1.02 Million
Q4 2020

Feb 12, 2021

SELL
$101.87 - $151.79 $2.52 Million - $3.75 Million
-24,700 Reduced 61.89%
15,207 $2.31 Million
Q3 2020

Nov 13, 2020

BUY
$99.9 - $121.13 $3.4 Million - $4.12 Million
34,007 Added 576.39%
39,907 $4.03 Million
Q2 2020

Aug 13, 2020

SELL
$92.74 - $125.82 $222,576 - $301,968
-2,400 Reduced 28.92%
5,900 $714,000
Q1 2020

May 14, 2020

BUY
$79.39 - $115.35 $658,937 - $957,405
8,300 New
8,300 $787,000
Q2 2019

Aug 13, 2019

SELL
$76.06 - $120.81 $433,542 - $688,617
-5,700 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$107.15 - $126.84 $53,575 - $63,420
-500 Reduced 8.06%
5,700 $669,000
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $20,228 - $23,662
200 Added 3.33%
6,200 $702,000
Q1 2018

May 15, 2018

BUY
$107.21 - $151.94 $385,956 - $546,984
3,600 Added 150.0%
6,000 $674,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,400
2,400 $311,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.